- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- What’s driving physicians to early retirement
- Why Tenet’s CEO says ASCs keep choosing USPI
- 12 recent hospital, health system president exits
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- 32 health systems spending $5B on cancer care
- Sanford, North Memorial planned combination adds to Minnesota healthcare deal wave
- Lone Peak Dental Group acquires Arizona practice
- Inside Northwestern Medicine’s battle against surgeon burnout
- UT Austin launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- Trump plans to fire FDA chief Marty Makary: report
- Trump plans to fire FDA chief Marty Makary: report
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- 5 DSOs making headlines
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS execs say company on track to meet MA margin goals by 2028
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
The Department of Health and Human Services will use the Defense Production Act to increase investments in essential medicines and medical countermeasures:
https://www.reuters.com/world/us/biden-invoke-cold-war-era-law-boost-medical-supplies-2023-11-27/
Biden to invoke Cold War-era law to boost medical supplies
By Jason Lange and Jeff Mason - November 27, 2023WASHINGTON, Nov 27 (Reuters) - President Joe Biden will invoke a Cold War-era measure to boost investment in U.S. manufacturing of medicines and medical supplies that he has deemed important for national defense, the White House said.
The announcement is part of a series of measures the Biden administration is unveiling on Monday to help industrial supply chains and counter several years of historically high inflation.
Biden will authorize the Department of Health and Human Services to use powers under the Cold War-era Defense Production Act to enable investments in "essential medicines," the White House said in a statement.
The areas of investment also include "medical countermeasures," which include supplies that diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear attacks.
Biden, a Democrat who is running for re-election in 2024, is eager to show Americans that he is tackling inflation and addressing broad concerns about the state of the U.S. economy. He is holding his first meeting of a new White House Council on Supply Chain Resilience on Monday.
Lael Brainard, head of Biden's National Economic Council, told reporters on a conference call that supply chain stress had come down from record highs hit during the COVID-19 pandemic but more work was left to be done.
We are about to find out whether the shortages of medicines are contrived to increase the profits of pharmaceutical manufacturers.
I don't think they much care where the money comes from, as long as it's flowing in their direction.
What would happen if all Medicare did was cut people checks, like Social Security does?
Mackinac Center's Overton Window Podcast featured a guest with that remarkable idea for reform.
‘That is what makes health care so different from every other sector of the economy’
Brian Blase on putting the customer back in the health care system
November 3, 2023 |When will health care costs stop going up? Perhaps when people start putting normal market mechanisms on the services, says Brian Blase, president of the Paragon Health Institute. I speak with him about it for the Overton Window podcast.Blase says that people are generally satisfied when they have coverage through private insurance or through the government programs Medicare and Medicaid.
Part of the reason for this is third-party payments. Insurers pay medical providers on behalf of the people they cover. And taxpayers cover the costs for people enrolled in Medicare and Medicaid.
“We’ve done a pretty good job of suppressing who pays for all the health care spending. We’ve dispersed so much of the cost to taxpayers,” Blase says.
“Health insurance is not a typical insurance product. Think of typical insurance products: life insurance, homeowners insurance, your car insurance,” Blase says.
You are protecting yourself against financial ruin, right? It’s a very low-probability event. Obviously, that’s present in health care. You can get involved in an accident, you could develop a very expensive medical condition like cancer. That’s a relatively low probability but carries high financial cost. A large part of what health insurance also does is prepayment of medical services. It is the individual giving up negotiation and control to a third party, whether that third party is a government bureaucracy or a health insurance company or an employer.
Third-party payments also get in the way of efficient and effective provisions when the third party sets so many of the terms of service.
“One of the central features is that a federal bureaucracy in Washington, D.C., decides what gets reimbursed and what the reimbursement prices are,” Blase says. Medical decisions are determined by a political process rather than by a market process.
“And private insurers have tended to just go with Medicare’s reimbursement rates, which I think is a real problem,” Blase says.
This creates harms akin to those created by government price controls. “When it’s set too high or too low, you have problems,” Blase says. Shortages or surpluses develop, too much of one kind of services and not enough of others.
There are further complications stemming from the legal restrictions on the supply of medical care. Certificate of need laws hinder companies from building more hospitals, for instance. “And by the way, incumbent firms can sit on the boards of these certificate of need panels, which deny permission to competitors to come into the market,” Blase says.
Scope of practice rules also stop qualified nurse practitioners and physicians assistants from serving customers at lower costs, Blase says.
Subsidizing demand while restricting supply inflates prices and raises health care spending. “If I were to give you my main frustration with the American health care system, it’s that we have created a whole bunch of perverse incentives so that Americans who make decisions aren’t focusing on value,” Blase says.
Too many health care providers look to protect themselves from competition. When costs increase, they recommend spending more on subsidies. Lawmakers have taken their side, and this has kept costs on the rise.
Blase’s solution is to apply the processes that make markets work. Providers should earn profits when they find ways to deliver better services at lower costs. People should encourage competition by shopping around for quality services at good prices.
He’d like to see Medicare change from a centrally planned benefit to a plan “where the incentives are there for the enrollee to make the decisions that best work for them.”
Blase would also stop employers from determining the health insurance plans for their employees. “There’s not another major financial product that people purchase that the employer decides for the employees what the best product for all the employees are,” Blase says.
Instead, he’d let the money employers pay for employees’ insurance go to the employee to make insurance purchases. They’d get the same tax advantages that employers receive for insurance, too.
“Anything that we can do, on the margin, to move away from third-party payment to first-party payment improve the consumer’s ability to shop and get value,” Blase says.
There have been signs of progress. Congress has introduced Medicare premium support plans, where a portion of government payments could be directed by beneficiaries.
Medicare Advantage programs, which pay for health costs not covered by Medicare, have become more prevalent. Their continued growth can provide a more robust market for seniors than is available with Medicare. “Half of Medicare enrollees are in Medicare Advantage plans right now,” Blase says.
He notes that there are attempts to do better things around the third-party payments and price control problems in the market. California, for instance, manages a large health insurance program for retired government workers and offers reference prices to help beneficiaries control costs. People can pocket some savings if they can find medical providers who would perform the service for less than the reference price.
“When they had that incentive, consumers started shopping,” Blase says. “The most interesting part of this, though, is that high-priced hospitals in that area didn’t like the fact that they were losing customers. So they reduced prices significantly.”
Part of his work is to document the different models that people are trying, in order to to see if they can do this better. “We don’t want the government to regulate all of these alternatives out of existence,” Blase says.
“That’s why I do health care policy, right? We want people to have better health care access and get the best care available to them,” Blase says. “In order to improve health care access, we’ve got to reduce prices. We’ve got to undo all of these government programs and policies that have created such perverse incentives.”
Check out the conversation at the Overton Window podcast.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













